TheProfitWatch

ZURA - Zura Bio Limited Class A Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.72 -0.04 (-1.08%) --- --- --- -0.1 (-2.69%) 0.1 (2.76%) 0.01 (0.27%) 0.01 (0.27%)

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.17
Diluted EPS:
-0.17
Basic P/E:
-21.6471
Diluted P/E:
-21.6471
RSI(14) 1m:
0.0
VWAP:
3.68
RVol:

Events

Period Kind Movement Occurred At

Related News